BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24805831)

  • 1. Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis.
    Yan Y; Han F; Fu H; Xia W; Qin X
    Tumour Biol; 2014 Aug; 35(8):7707-12. PubMed ID: 24805831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant association between MTHFR C677T polymorphism and thyroid cancer risk: evidence from a meta-analysis.
    Chen Y; Wang B; Yan S; Wang YG
    Genet Test Mol Biomarkers; 2014 Oct; 18(10):695-702. PubMed ID: 25007377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
    Ma C; Liu Y; Zhang W; Liu P
    Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between
    Tan X; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1273218. PubMed ID: 37964957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
    Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
    Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.
    Wu YL; Yang HY; Ding XX; Zhao X; Chen J; Bi P; Sun YH
    Seizure; 2014 Jun; 23(6):411-6. PubMed ID: 24556013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
    Lv L; Wang P; Sun B; Chen G
    Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the C677T polymorphism in MTHFR gene and the risk of thyroid cancer: a meta-analysis.
    Yang YM; Zhang TT; Yuan L; Ren Y
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2097-101. PubMed ID: 25070812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies.
    Wu YL; Ding XX; Sun YH; Yang HY; Chen J; Zhao X; Jiang YH; Lv XL; Wu ZQ
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():78-85. PubMed ID: 23831680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
    Yi K; Yang L; Lan Z; Xi M
    Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between MTHFR C677T Gene polymorphism with alcohol dependence: A meta-analysis of case-control studies.
    Xu R; Wu H; Zhang S; Zhou H; Liang L
    Neurosci Lett; 2018 Sep; 683():69-74. PubMed ID: 29953924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
    Bai R; Liu W; Zhao A; Zhao Z; Jiang D
    Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
    Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Wu YL; Ding XX; Sun YH; Yang HY; Sun L
    J Neurol Sci; 2013 Dec; 335(1-2):14-21. PubMed ID: 24064257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and male infertility risk: An updated meta-analysis.
    Han LJ; He XF; Ye XH
    Medicine (Baltimore); 2020 Dec; 99(51):e23662. PubMed ID: 33371103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.
    Yu L; Chang K; Han J; Deng S; Chen M
    PLoS One; 2013; 8(2):e55835. PubMed ID: 23431363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of the association between MTHFR C677T polymorphism and hemorrhagic stroke risk.
    Zhao X; Jiang H
    Mol Biol Rep; 2013 Jan; 40(1):573-8. PubMed ID: 23184002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MTHFR C677T and A1298C Polymorphisms on Migraine Susceptibility: A Meta-Analysis of 26 Studies.
    Liu L; Yu Y; He J; Guo L; Li H; Teng J
    Headache; 2019 Jun; 59(6):891-905. PubMed ID: 31045246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the MTHFR C677T polymorphism with primary brain tumor risk.
    Xu C; Yuan L; Tian H; Cao H; Chen S
    Tumour Biol; 2013 Dec; 34(6):3457-64. PubMed ID: 23846816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.